Risk stratification for prevention of venous thromboembolism in hospitalized medical patients: can thromboprophylaxis in hospitalized medical patients be safely restricted to reduce costs?
Share
Please join us …
When: Tuesday, October 10, 2017, 12–1 p.m.
Where: ICES, G-Wing, Conference Centre (Sunnybrook Health Sciences Centre)
Who: Alison Bond, PharmD; Sunnybrook Health Sciences Centre, Thromboembolism Pharmacy Fellow.
Topic: Risk stratification for prevention of venous thromboembolism in hospitalized medical patients: can thromboprophylaxis in hospitalized medical patients be safely restricted to reduce costs?
Learning objectives
To describe the benefits and harms of thromboprophylaxis
To summarize the evidence to support thromboprophylaxis in GIM patients
To evaluate the potential impact of risk assessment models for thromboprophylaxis in GIM patients.